- Home
- CRNX vs ITGR Comparison
CRNX vs ITGR Comparison
Compare CRNX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ITGR
- Stock Information
- Founded
- CRNX 2008
- ITGR 1970
- Country
- CRNX United States
- ITGR United States
- Employees
- CRNX N/A
- ITGR N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRNX Health Care
- ITGR Health Care
- Exchange
- CRNX Nasdaq
- ITGR Nasdaq
- Market Cap
- CRNX 5.2B
- ITGR 4.7B
- IPO Year
- CRNX 2018
- ITGR 2000
- Fundamental
- Price
- CRNX $37.46
- ITGR $129.98
- Analyst Decision
- CRNX Strong Buy
- ITGR Strong Buy
- Analyst Count
- CRNX 12
- ITGR 9
- Target Price
- CRNX $72.64
- ITGR $149.00
- AVG Volume (30 Days)
- CRNX 747.4K
- ITGR 290.0K
- Earning Date
- CRNX 02-27-2025
- ITGR 02-20-2025
- Dividend Yield
- CRNX N/A
- ITGR N/A
- EPS Growth
- CRNX N/A
- ITGR 25.19
- EPS
- CRNX N/A
- ITGR 3.37
- Revenue
- CRNX $1,038,999.00
- ITGR $1,716,596,000.00
- Revenue This Year
- CRNX N/A
- ITGR $9.73
- Revenue Next Year
- CRNX $206.01
- ITGR $7.31
- P/E Ratio
- CRNX N/A
- ITGR $38.20
- Revenue Growth
- CRNX N/A
- ITGR 7.51
- 52 Week Low
- CRNX $34.07
- ITGR $99.63
- 52 Week High
- CRNX $62.53
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- CRNX 42.29
- ITGR 33.65
- Support Level
- CRNX $35.10
- ITGR $136.27
- Resistance Level
- CRNX $35.85
- ITGR $144.76
- Average True Range (ATR)
- CRNX 1.45
- ITGR 3.98
- MACD
- CRNX 0.47
- ITGR -0.99
- Stochastic Oscillator
- CRNX 49.78
- ITGR 9.38
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.